Furosemide Oral Solution
Brand names: Furosemide
Category: Cardiovascular
FDA status: Current · Last FDA update: Sep 18, 2026 · First posted: Mar 31, 2026 (in shortage 6 months) · 1 manufacturers, 3 listed presentations
As of Sep 18, 2026, the FDA lists Furosemide Oral Solution as currently in shortage. Of 3 manufacturer presentations, 1 Limited, 2 Available.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50) NDC 0054-3294-50 |
Hikma Pharmaceuticals USA, Inc. | Limited | Available on allocation |
| Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46) NDC 0054-3294-46 |
Hikma Pharmaceuticals USA, Inc. | Available | - |
| Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63) NDC 0054-3298-63 |
Hikma Pharmaceuticals USA, Inc. | Available | - |
Related medications in shortage
Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Furosemide Oral Solution (FDA data as of Sep 18, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Furosemide Oral Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/furosemide-oral-solution.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).